コンテンツへスキップ
Merck

MABF933

Anti-SAMHD1 Antibody, clone I19-18

で組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する

この商品について

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
I19-18, monoclonal
Application:
FACS, ICC, WB
Citations:
-
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


conjugate

unconjugated

Quality Segment

antibody form

purified antibody

clone

I19-18, monoclonal

purified by

using protein G

species reactivity

mouse, human

concentration

(Please refer to lot specific datasheet.)

technique(s)

flow cytometry: suitable, immunocytochemistry: suitable, western blot: suitable

isotype

IgG1κ

UniProt accession no.

target post-translational modification

unmodified

General description

GST-tagged recombinant full-length human SAMHD1.
~72 kDa observed. 72.2 kDa (isoform 1), 69.4 kDa (isoform 2), 63.7 kDa (isoform 3), 68.1 kDa (isoform 4) calculated.

Application


Flow Cytometry Analysis: A representative lot detected a downregulated SAMHD1 immunoreactivity among cutaneous T cell lymphoma (CTCL) patients-derived CD4+ PBMCs when comparing to CD4+ PBMCs from healthy donors (de Silva, S., et al. (2014). J. Invest. Dermatol. 134(2):562-565).
Flow Cytometry Analysis: A representative lot detected SAMHD1 immunoreactivity in CD123+ plasmacytoid dendritic cells (pDCs) from human PBMCs and a downregulated SAMHD1 immunoreactivity in pDCs when cocultivated with PHA–IL-2-activated CD4+ T cells (Su, B., et al. (2014). J. Virol.88(18):10975-10981).
Flow Cytometry Analysis: A representative lot detected SAMHD1 immunoreactivity in non-infected monocyte-derived dendritic cells (MDDCs) and a greatly reduced SAMHD1 immunoreactivity in MDDCs exposed to virion-like particles (VLPs) generated from wild-type SIV-3 (simian immunodeficiency virus type 3)-positive plasmid (Puigdomènech, I., et al. (2013). J. Virol.87(5):2846-2856).
Western Blotting Analysis: A representative lot detected SAMHD1 in lysates from non-infected monocyte-derived dendritic cells (MDDCs), but not in MDDCs exposed to virion-like particles (VLPs) generated from wild-type SIV-3 (simian immunodeficiency virus type 3)-positive plasmid (Puigdomènech, I., et al. (2013). J. Virol.87(5):2846-2856).
Immunocytochemistry Analysis: 2.0 µg/mL from a representative lot detected SAMHD1 in THP-1 cells.
Western Blotting Analysis: A representative lot detected a downregulation of intracellular SAMHD1 in primary human dendritic cells (DCs) following infection by virion-like particles (VLPs) generated from wild-type SIV-3 (simian immunodeficiency virus type 3)-positive plasmid (Courtesy of Dr. Olivier Schwartz, Institut Pasteur, Paris, France).
Immunocytochemistry Analysis: 1.0 µg/mL from a representative lot detected SAMHD1 expression in THP1 human monocytic cells by fluorescent immunocytochemistry (Courtesy of Dr. Olivier Schwartz, Institut Pasteur, Paris, France).
Flow Cytometry Analysis: 0.4 µg/mL from a representative lot detected a downregulation of intracellular SAMHD1 in primary human dendritic cells (DCs) following infection by virion-like particles (VLPs) generated from wild-type SIV-3 (simian immunodeficiency virus type 3)-positive plasmid (Courtesy of Dr. Olivier Schwartz, Institut Pasteur, Paris, France).
Flow Cytometry Analysis: A representative lot detected a downregulated SAMHD1 immunoreactivity among CD4+ PBMCs 5 days post infection by a laboratory-adapted HIV-2 strain (ROD) or by two other HIV-2 isolates (TOE and ROK) from infected patients (Chauveau, L., et al. (2015). Retovirology. 12:2).

Physical form

Purified mouse monoclonal IgG1κ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

Preparation Note

Stable for 1 year at 2-8°C from date of receipt.

Analysis Note

Evaluated by Western Blotting in THP-1 cell lysate.

Western Blotting Analysis: 0.5 µg/mL of this antibody detected SAMHD1 in 10 µg of THP-1 cell lysate.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.


保管分類

10 - Combustible liquids



試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする